Adamis: Q2 Earnings Snapshot

August 10, 2022 GMT

SAN DIEGO (AP) _ Adamis Pharmaceuticals Corp. (ADMP) on Wednesday reported a loss of $8.4 million in its second quarter.

On a per-share basis, the San Diego-based company said it had a loss of 6 cents.

The biopharmaceutical company posted revenue of $39,800 in the period. Its adjusted revenue was $40,000.

In the final minutes of trading on Wednesday, the company’s shares hit 37 cents. A year ago, they were trading at $1.01.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on ADMP at